latest news releases from the newsroom
Enea Signs General Agreement With Leading Telecom Provider
TABY, Sweden, June 28, 2004 (PRIMEZONE) -- Enea has signed a new product frame agreement with Ericsson. The multi-year agreement is based on a new licensing model and covers OSE products for Ericsson's 3G platforms for telecom systems products as well as mobile phone products.
Vitrolife Products Receive European Approval
STOCKHOLM, Sweden, June 28, 2004 (PRIMEZONE) -- Vitrolife has received European approval (CE mark) for a complete series of products within ART (Assisted Reproductive Technology). "This gives us competitive strength in established markets and enables us to more easily introduce the products on new markets," says Tony Winslof, Director of Marketing at Vitrolife.
Brower Piven, A Professional Corporation
Law Offices Of Charles J. Piven, P.A. Announces Class Action Lawsuit Against drugstore.com, inc. -- DSCM
BALTIMORE, June 26, 2004 (PRIMEZONE) -- Law Offices Of Charles J. Piven, P.A. today announced that a securities class action was commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of drugstore.com, inc., (Nasdaq:DSCM) ("drugstore.com" or the "Company") from January 20, 2004 through June 10, 2004 inclusive (the "Class Period").
Murray, Frank & Sailer LLP
Murray, Frank & Sailer Llp Announces Class Action Lawsuit On Behalf Of Purchasers Of Corporate Backed Trust Certificates Verizon New York Debenture-Backed Series 2004-1 -- JZG
NEW YORK, June 25, 2004 (PRIMEZONE) -- Murray, Frank & Sailer LLP announces that a class action lawsuit was filed in the United States District Court for the Southern District of New York on behalf of all persons who purchased Corporate Backed Trust Certificates Verizon New York Debenture-Backed Series 2004-1 (NYSE:JZG) (CUSIP:21988K800) (the "Certificates") from their first offering on or about January 5, 2004 through and including May 11, 2004 pursuant to a prospectus dated November 8, 2002, as supplemented by prospectus supplements dated January 5, 2004 and January 20, 2004 (collectively, the "Prospectus").